Topic

Insurance Approval

A collection of 5281 issues

Work With Your Doctor to Get Trikafta Approved by Cigna in New York: Complete PA Guide and Appeal Process

Answer Box: Getting Trikafta Approved by Cigna in New York Cigna requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) in New York. Your CF specialist must submit genetic testing showing F508del or responsive CFTR mutation, diagnosis confirmation (ICD-10 E84.0), and medical necessity documentation. Submit electronically via CoverMyMeds for fastest
7 min read

The Requirements Checklist to Get Advate (octocog alfa) Covered by UnitedHealthcare in Illinois: Complete PA and Appeal Guide

Answer Box: Getting Advate Covered by UnitedHealthcare in Illinois Advate (octocog alfa) requires prior authorization through UnitedHealthcare's OptumRx with step therapy requirements favoring preferred Factor VIII products. The fastest path to approval: 1) Submit complete PA with hemophilia A diagnosis (ICD-10: D66), inhibitor-negative status, and bleeding history via
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in Florida Yes, UnitedHealthcare covers Ocrevus (ocrelizumab) for multiple sclerosis, but requires prior authorization with specific documentation. Your neurologist submits the PA request through the UHC Provider Portal or by fax to 866-940-7328, including MS diagnosis confirmation, hepatitis B screening results, and evidence
6 min read

How to Get Elevidys Gene Therapy Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Started To get Elevidys (delandistrogene moxeparvovec-rokl) covered by Aetna CVS Health in New York: Submit prior authorization through the Availity portal with genetic confirmation, ambulatory status documentation, and approved infusion center verification. If denied, file internal appeal within 180 days, then New York external appeal within 4
6 min read